Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032

Keyphrases

• Activator protein-1 (AP-1) 14%
• Additional Treatment 7%
• C-Jun 35%
• Cell Proliferation 7%
• Chemopreventive 7%
• Colony Formation 7%
• Common Cancers 7%
• Core Members 7%
• Cutaneous Squamous Cell Carcinoma (cSCC) 21%
• Dose Effect 7%
• Healthy Skin 7%
• Inflammation 7%
• Kinase Cascade 7%
• Knockdown 7%
• Non-melanoma Skin Cancer 7%
• Phosphorylation 7%
• Phosphorylation State 7%
• Protein Kinase Inhibitors 100%
• Protein Kinase Signaling 7%
• Serine-threonine Kinase 7%
• SKH-1 Hairless Mice 14%
• Skin Cancer 7%
• Skin Cancer Cells 7%
• Skin Carcinogenesis 100%
• Skin Tissue 7%
• Solar Ultraviolet Radiation 100%
• Specific Inhibitor 7%
• T-LAK Cell-originated Protein Kinase 100%
• Targeted Therapy 7%
• Topical Application 7%
• Transactivation 7%
• Ultraviolet Exposure 7%
• Ultraviolet Irradiation 7%
• Ultraviolet-induced 100%
• United States 7%

Medicine and Dentistry

• Cancer Cell 7%
• Cell Line 7%
• Cell Proliferation 7%
• Cell Signaling Pathway 7%
• Colony Formation 7%
• Cyclic AMP Dependent Protein Kinase 7%
• Kinase Signaling 7%
• Malignant Neoplasm 7%
• Non Melanoma Skin Cancer 7%
• Protein Kinase Inhibitor 100%
• Protein Kinases 100%
• Protein Serine Threonine Kinase 7%
• Skin Cancer 15%
• Skin Carcinogenesis 100%
• Skin Carcinoma 23%
• Targeted Therapy 7%
• Topical Drug Administration 7%
• Transactivation 7%
• Ultraviolet Irradiation 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Cyclic AMP Dependent Protein Kinase 7%
• Hairless Mouse 15%
• Inflammation 7%
• Malignant Neoplasm 7%
• Non Melanoma Skin Cancer 7%
• Protein Kinase Inhibitor 100%
• Protein Kinases 100%
• Protein Serine Threonine Kinase 7%
• Skin Cancer 15%
• Skin Carcinogenesis 100%
• Skin Carcinoma 23%
• Ultraviolet Irradiation 7%